GLAXOSMITHKLINE PLC 13D/13G Filings for F-star Therapeutics, Inc. (FSTX)

GLAXOSMITHKLINE PLC 13D and 13G filings for F-star Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-10
4:50 pm
Sale		 2021-12-31 13G F-star Therapeutics, Inc.
FSTX		 GLAXOSMITHKLINE PLC 802,627
3.900%		 -1,295decrease
(-0.16%)		 Filing
2020-11-30
5:05 pm
Purchase		 2020-11-20 13G F-star Therapeutics, Inc.
FSTX		 GLAXOSMITHKLINE PLC 803,922
8.900%		 803,922increase
(New Position)		 Filing